Comparison
CJC-1295 vs Sermorelin
Two GHRH-side peptides with different half-lives — daily-style sermorelin against the longer-acting CJC-1295.
CJC-1295 and Sermorelin both show up in the same conversations, but they aren't interchangeable. The table above lays the vial math side by side so you can see how concentration, doses-per-vial, and weekly cadence actually compare. The sections below walk through what each one is, how each is studied, and how each shows up in a tracked log — in plain English, no recommendations.
Tiebreakers
Where CJC-1295 and Sermorelin actually diverge
| CJC-1295 | Sermorelin | |
|---|---|---|
| Cadence | 7/wk | 7/wk |
| Concentration on example | 1.00 mg/mL | 2.50 mg/mL |
| Math weeks per vial | 2.9 | 3.6 |
| Category | GH Secretagogue | GH Secretagogue |
Bolded values are the higher of the two on numeric rows. Same-value rows aren't a verdict — they're shared properties.
CJC-1295 vs Sermorelin: the actual decision
Both of these molecules sit on the GHRH side of the secretagogue pathway, so the mechanism overlap is genuine — the practical comparison is half-life and cadence, not target receptor. Sermorelin is the original GHRH(1-29) fragment with a half-life of roughly 10–20 minutes; CJC-1295 in its DAC form is a modified analog with a half-life measured in days. That single chemistry change is the reason these two molecules look so different in a log even though they bind the same receptor.
Cadence in a tracker reflects the half-life difference directly. Sermorelin protocols are written around daily, often pre-bed administration to ride the natural overnight GH pulse — the half-life is too short for any other rhythm to make biological sense. CJC-1295 with DAC sits at the other extreme, with twice-weekly dosing being the most common cadence in the published off-label protocols. The two molecules cannot share the same calendar shape, which is the most-tracked difference in head-to-head logs.
Mechanism, cadence, and what shows up in a log
Pulse pattern is the more subtle difference. Sermorelin produces a sharp, short GH pulse that resembles the body's natural overnight pattern; CJC-1295 with DAC produces sustained elevation that is more of a tonic shift than a pulse. Researchers who care about preserving pulsatility tend to log sermorelin; researchers who prioritize cumulative exposure and convenience tend to log CJC-1295. Neither pattern is inherently better — they are different shapes of the same underlying signal.
Reconstitution is identical between the two molecules in mechanics, and the unit math on a 100-unit syringe is similar at typical vial sizes. The big practical difference shows up on the vial-duration calculator: a 5 mg sermorelin vial dosed daily empties faster than a 5 mg CJC-1295 vial dosed twice weekly even when the per-dose milligrams are similar, simply because of the cadence. The calculator linked below shows the gap at your own example vials.
CJC-1295 vs Sermorelin: the numbers, side by side
Start with what actually goes into a syringe. The example CJC-1295 vial on this site reconstitutes 2 mg in 2 mL of bacteriostatic water — about 1.00 mg per mL, which yields roughly 20 doses at the 100 mcg example and lasts about 2.9 weeks at 7 doses per week. The example Sermorelin vial reconstitutes 5 mg in 2 mL (2.50 mg/mL), which yields about 25 doses at 200 mcg and stretches roughly 3.6 weeks at 7 doses per week. Those numbers are the starting point most people forget to write down, and they decide everything downstream — refill timing, unit count on the syringe barrel, and whether a 30-mL bac-water bottle stretches across one vial or two.
Category context matters too. Both CJC-1295 and Sermorelin sit in the GH Secretagogue bucket, so the head-to-head questions readers bring here are usually about cadence, titration step size, and which of the two molecules logs more cleanly inside a longer protocol rather than a from-scratch category choice. Cadence helps frame the rest: CJC-1295 is logged about 7× per week in the example schedule, Sermorelin about 7×.
The single most-asked-about mistake on each page is worth surfacing here, because they rarely overlap. On the CJC-1295 side: Applying a daily dosing frequency appropriate for the no-DAC variant to the long-acting DAC variant. On the Sermorelin side: Mistaking its short half-life for a lack of activity and consequently attempting to use multi-day dosing intervals. Both are the kind of thing a tracked log catches early and an untracked routine catches late.
The primary difference is the half-life and resulting dosing schedule. The DAC (Drug Affinity Complex) allows the peptide to bind to albumin in the blood, extending its half-life to about 6-8 days and enabling weekly or twice-weekly administration. The no-DAC version has a half-life of only about 30 minutes, requiring daily or multiple daily administrations to be studied.
Sermorelin is structured as the N-terminal fragment of native Growth Hormone-Releasing Hormone because extensive research identified this segment as the biologically active region. These 29 amino acids are sufficient for binding to and stimulating the GHRH receptor with the same efficacy as the full 44-amino-acid hormone. The remaining C-terminal portion of the natural peptide is not required for this primary function.
The calculator pages linked below let you swap your own vial size, diluent volume, and dose into the same math — these example numbers exist so the comparison renders with concrete figures instead of placeholders.
Frequently asked questions about CJC-1295 vs Sermorelin
What is the functional difference between CJC-1295 with DAC and without DAC?
Why is CJC-1295 without DAC frequently paired with ipamorelin in research?
For a 2 mg vial reconstituted with 2 mL of water, how many units is a 100 mcg dose?
Why is Sermorelin composed of only the first 29 amino acids of GHRH?
What is meant by a 'pulse-preserving' stimulus in the context of Sermorelin?
Why is Sermorelin's dosing schedule typically set for right before bed?
Related on Peptide Pilot
- Open
CJC-1295 reference
Overview, mechanism, mistakes, and FAQs.
- Open
Sermorelin reference
Overview, mechanism, mistakes, and FAQs.
- Open
CJC-1295 calculators
Reconstitution, dose, mg ↔ units, vial duration.
- Open
Sermorelin calculators
Reconstitution, dose, mg ↔ units, vial duration.
- Open
All peptide comparisons
Browse the full list of side-by-side reference pages.
- Open
CJC-1295 vs Ipamorelin
The classic GH-secretagogue pairing — a GHRH analog next to a GHRP, different pulse mechanics, often logged as a stack.
- Open
Sermorelin vs Tesamorelin
Sermorelin against tesamorelin — both GHRH analogs, very different half-lives and very different studied populations.
- Open
Mod GRF 1-29 vs CJC-1295
Mod GRF 1-29 (CJC-1295 without DAC) next to long-acting CJC-1295 with DAC — same backbone, very different half-life and dosing cadence.